Advertisement

Digestive Diseases and Sciences

, Volume 49, Issue 11–12, pp 1946–1952 | Cite as

Admission Hematocrit: A Simple, Useful and Early Predictor of Severe Pancreatitis

  • S. Ian Gan
  • Joseph Romagnuolo
Article

Abstract

Existing predictor systems of severe pancreatitis are cumbersome and can require up to 48 hr to complete. This study aimed to determine whether useful likelihood ratios exist for the prediction of severe pancreatitis, corresponding to various ranges of admission hematocrit. A retrospective cohort of 200 patients admitted with acute pancreatitis was identified. Likelihood ratios were calculated for a priori defined hematocrit ranges. Using multivariate logistic regression, initial hematocrit was evaluated as a predictor of severe pancreatitis as defined a priori by local and/or systemic complications (Atlanta criteria, 1992). Planned subgroup analysis was performed on those with a hematocrit >50%, stratified by 24-hr hematocrit. Fourteen patients (7%) developed severe pancreatitis. Likelihood ratios were 0.45, 0.70, and 7.5 for hematocrit ranges of ≤45, 45.1–49.9, and ≥50%, respectively. Hematocrit (as increases by 5%) was a significant predictor of severe pancreatitis (odds ratio [OR] = 2.8; P=0.001), length of stay (P&<0.0001), necrosis (OR = 3.9; P=0.001), and need for intensive care (OR 4.5; P=0.002). The negative predictive value of the lowest range and positive predictive value of the highest range were 97% (95% Cl: 92–99%) and 37% (16–62%), respectively. Lack of normalization of hematocrit by 24 hr did not predict severe pancreatitis. Initial hematocrit appears to be an early, simple, and useful predictor of severe pancreatitis. A normal 24-hr hematocrit does not appear to alter the prediction made by the initial hematocrit.

hematocrit pancreatitis clinical predictors likelihood ratios-7 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Toouli J, Brooke-Smith, M, Bassi C: Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 17S:S15–S39, 2002CrossRefGoogle Scholar
  2. 2.
    Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC: Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstetr 139(1):69–81, 1974Google Scholar
  3. 3.
    Blamey SL, Imrie CW, O’Neill J, Gilmour WH, Carter DC: Prognostic factors in acute pancreatitis. Gut 25(12):1340–1346, 1984CrossRefGoogle Scholar
  4. 4.
    Wilson C, Heath DI, Imrie CW: Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 77(11):1260–1264, 1990CrossRefGoogle Scholar
  5. 5.
    Corfield AP, Cooper MJ, Williamson RC, et al.: Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices. Lancet 2(8452):403–407, 1985CrossRefGoogle Scholar
  6. 6.
    Larvin M, McMahon MJ: APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 2(8656):201–205, 1989CrossRefGoogle Scholar
  7. 7.
    Agarwal N, Pitchumoni CS: Assessment of severity in acute pancreatitis. Am J Gastroenterol 86(10):1385–1391, 1991PubMedGoogle Scholar
  8. 8.
    McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW: High early mortality rate from acute pancreatitis in Scotland, 1984–1995. Br J Surg 86(10):1302–1305, 1999CrossRefGoogle Scholar
  9. 9.
    Neoptolemos JP, Carr-Locke DL, London NJ, Bailey IA, James D, Fossard DP: Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 2(8618):979–983, 1988CrossRefGoogle Scholar
  10. 10.
    Fan ST, Lai EC, Mok FP, Lo CM, Zheng SS, Wong J: Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med 328(4):228–232, 1993CrossRefGoogle Scholar
  11. 11.
    Nowak A, Marek TA, Nowakowska-Dulawa E, Rybicka J, Kaczor R: Biliary pancreatitis needs endoscopic retrograde cholangiopancreatography with endoscopic sphincterotomy for cure. Endoscopy 30(9):A256–A259, 1998PubMedGoogle Scholar
  12. 12.
    Folsch UR, Nitsche R, Ludtke R, Hilgers RA, Creutzfeldt W: Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. N Engl J Med 336(4):237–242, 1997CrossRefGoogle Scholar
  13. 13.
    Uhl W, Buchler M, Malfertheiner P, Martini M, Beger HG: PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 6(3):253–259, 1991CrossRefGoogle Scholar
  14. 14.
    Wereszczynska S, Dabrowski A, Jedynak M, Gabryelewicz A: Oxidative stress as an early prognostic factor in acute pancreatitis (AP): Its correlation with serum phospholipase A2 (PLA2) and plasma polymorphonuclear elastase (PMN-E) in different-severity forms of human AP. Pancreas 17(2):163–168, 1998CrossRefGoogle Scholar
  15. 15.
    Gudgeon AM, Heath Dl, Hurley P, et al.: Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 335(8680):4–8, 1990CrossRefGoogle Scholar
  16. 16.
    Bird NC, Goodman AJ, Johnson AG: Serum phospholipase A2 activity in acute pancreatitis: An early guide to severity. Br J Surg 76(7):731–732, 1989CrossRefGoogle Scholar
  17. 17.
    Pezzilli R, Miniero R, Cappelletti O, Barakat B: Serum interleukin 6 in the prognosis of acute biliary pancreatitis. Dig Liver Dis 30(3):291–294, 1998Google Scholar
  18. 18.
    Mayer JM, Raraty M, Slavin J, et al.: Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg 89(2):163–171, 2002PubMedGoogle Scholar
  19. 19.
    Leese T, Shaw D, Holliday M: Prognostic markers in acute pancreatitis: Can pancreatic necrosis be predicted? Ann Roy Coll Surg Engl 70(4):227–232, 1988Google Scholar
  20. 20.
    Baillargeon JD, Orav J, Ramagopal V, Tenner SM, Banks PA: Hemoconcentration as an early risk factor for necrotizing pancreatitis. Am J Gastroenterol 93(11):2130–2134, 1998CrossRefGoogle Scholar
  21. 21.
    Lankisch PG, Mahlke R, Blum T, et al.: Hemoconcentration : An early marker of severe and/or necrotizing pancreatitis? A critical appraisal. Am J Gastroenterol 96(7):2081–2085, 2001CrossRefGoogle Scholar
  22. 22.
    Pezzilli R, Morselli-Labate AM: Hematocrit determination (HCT) as an early marker associated with necrotizing pancreatitis and organ failure. Pancreas 22(4):433–435, 2001CrossRefGoogle Scholar
  23. 23.
    Andre EA, Costa PL, Guarita DR, Meirelles Filho JS, Laudanna AA: Changes in capillary permeability during severe experimental acute pancreatitis in rats. Rev Hosp Clin Facul Med Univ Sao Paulo 51(5):184–188, 1996Google Scholar
  24. 24.
    Hotz HG, Foitzik T, Rohweder J, et al.: Intestinal microcirculation and gut permeability in acute pancreatitis: Early changes and therapeutic implications. J Gastrointest Surg 2(6):518–525, 1998CrossRefGoogle Scholar
  25. 25.
    Knoefel WT, Kollias N, Warshaw AL, Waldner H, Nishioka NS, Rattner DW: Pancreatic microcirculatory changes in experimental pancreatitis of graded severity in the rat. Surgery 116(5):904–913, 1994PubMedGoogle Scholar
  26. 26.
    Romagnuolo J, Barkun AB, Joseph L: Interpretation of diagnostic tests. In Surgical Arithmetic: Epidemiological, Statistical and Outcome-Based Approach to Surgical Practice. Rosenberg L, Joseph L, Barkun AN, eds. pp 64–83. Landes Bioscience, 2000, Chap 3Google Scholar
  27. 27.
    Bradley EL 3rd: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 128(5):586–590, 1993CrossRefGoogle Scholar
  28. 28.
    Balthazar EJ, Ranson JH, Naidich DP, Megibow AJ, Caccavale R, Cooper MM: Acute pancreatitis: Prognostic value of CT. Radiology 156(3):767–772, 1985CrossRefGoogle Scholar
  29. 29.
    Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH: Acute pancreatitis: Value of CT in establishing prognosis. Radiology 174(2):331–336, 1990CrossRefGoogle Scholar
  30. 30.
    Joseph LGT: Inferences for likelihood ratios in the absence of a gold standard. Med Decision Making 16(4):412–417, 1996CrossRefGoogle Scholar
  31. 31.
    Gray S, Rosenman LD: Acute pancreatitis. The significance of hemoconcentration at admission to hospital. Arch Surg 91:485–488, 1965CrossRefGoogle Scholar
  32. 32.
    Brown A, Orav J, Banks PA: Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas 20(4):367–372, 2000CrossRefGoogle Scholar
  33. 33.
    Baron TH, Morgan DE: Acute necrotizing pancreatitis. N Engl J Med 340:1412–1417, 1999CrossRefGoogle Scholar
  34. 34.
    Sherman S, Lehman GA: ERCP and endoscopic sphincterectomy-induced pancreatitis. Pancreas 6:350, 1991CrossRefGoogle Scholar
  35. 35.
    Foitzik T, Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ: Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates. Surgery 128(3):399–407, 2000CrossRefGoogle Scholar
  36. 36.
    Klar E, Endrich B, Messmer K: Microcirculation of the pancreas. A quantitative study of physiology and changes in pancreatitis. Int J Microcirc Clin Exp 9(1):85–101, 1990PubMedGoogle Scholar
  37. 37.
    Sweiry JH, Mann GE: Pancreatic microvascular permeability in caerulein-induced acute pancreatitis. Am J Physiol 261(4, Pt 1):G685–G692, 1991CrossRefGoogle Scholar
  38. 38.
    Klar E, Herfarth C, Messmer K: Therapeutic effect of isovolemic hemodilution with dextran 60 on the impairment of pancreatic microcirculation in acute biliary pancreatitis. Ann Surg 211(3):346–353, 1990CrossRefGoogle Scholar
  39. 39.
    Paszkowski AS, Rau B, Mayer JM, Moller P, Beger HG: Therapeutic application of caspase 1/interleukin-1 beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis. Ann Surg 235(1):68–76, 2002CrossRefGoogle Scholar
  40. 40.
    Wang X, Sun Z, Borjesson A, et al.: Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis. Int J Pancreatol 25(1):45–52, 1999CrossRefGoogle Scholar
  41. 41.
    Virlos I, Siriwardena AK: Hypertonic saline attenuates end-organ damage in an experimental model of acute pancreatitisBr J Surg 87:1336–1340, 2000). Br J Surg 88(4), 2001Google Scholar
  42. 42.
    Huch K, Schmidt J, Schratt W, et al.: Hyperoncotic dextran and systemic aprotinin in necrotizing rodent pancreatitis. Scand J Gastroenterol 30(8):812–816, 1995CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2004

Authors and Affiliations

  • S. Ian Gan
    • 1
  • Joseph Romagnuolo
    • 1
    • 2
    • 3
  1. 1.Division of Gastroenterology, Department of Medicine, Advanced Therapeutic Endoscopy Centre GroupUniversity of CalgaryCalgaryCanada
  2. 2.Department of Community Health Sciences, Advanced Therapeutic Endoscopy Centre GroupUniversity of CalgaryCalgaryCanada
  3. 3.Medical University of South Carolina (MUSC)Charleston

Personalised recommendations